NSI-189 #
| Common Nomenclature | NSI-189 |
| Street & Reference Names | N/A |
| Reference Dosage | N/A |
| Maximum Dose Experienced | 40mg+20mg |
| Form | Pill |
| RoA | Oral |
| Source / Jurisdiction | Internet / UK |
SUBJECTIVE EXPERIENCE #
NSI-189 has been researched and investigated as a potential antidepressant, and as an agent for the treatment of cognitive impairment and neurodegeneration. Its efficacy has been vigorously debated over a number of years.
I pursued and sampled it following positive reports across a couple of specialist Internet forums.
Hardly surprisingly from a single experiment, I noticed very little. Like most nootropics it isn’t geared for recreational use.
Whilst I experienced no ill or negative effects, it is unlikely that I will return to it for any further testing.